
Overview
Seth P. Lerner, MD, is Professor of Urology and holds the Beth and Dave Swalm Chair in Urologic Oncology, in the Scott Department of Urology, Baylor College of Medicine. He is Director of Urologic Oncology and the Multidisciplinary Bladder Cancer Program and Faculty Group Practice Medical Director for the Urology Clinic. He earned his medical degree from Baylor College of Medicine, completed a surgical internship at Virginia Mason Hospital in Seattle, and returned to Baylor for his residency training. He completed a two-year fellowship at the University of Southern California in urologic oncology and reconstructive surgery under Peter Jones and Don Skinner before returning to join the full-time Baylor faculty in 1992. His clinical practice, education, and research activities are devoted to urologic oncology and particularly lower and upper tract urothelial cancer. Dr. Lerner is author of more than 160 peer-reviewed articles, and co-editor of a comprehensive Textbook of Bladder Cancer. Dr. Lerner is an active member of the prestigious American Association of Genitourinary surgeons and is listed routinely among America's Top Doctors and Best Doctors in America. He established and directs the multi-disciplinary Bladder Cancer Research Program at Baylor, and his research interests include use of selective estrogen receptor modulators for treatment of bladder cancer, gene therapy, targeted molecular therapeutics, and outcomes of radical cystectomy and pelvic lymphadenectomy. He has 22 years of experience as a clinical investigator for both NCI and industry funded clinical trials. He is the PI of the ongoing SWOG NCI Phase III trial comparing extended vs. standard pelvic lymphadenectomy at time of radical cystectomy for muscle invasive bladder cancer. He is active in the leadership of several national bladder cancer research enterprises including chair of the Local Bladder Cancer committee of SWOG, co-chair of the NCI's Bladder Cancer Task Force and the Analysis Working Group of The Cancer Genome Atlas Project for muscle invasive bladder cancer. He is very active in the Bladder Cancer Advocacy Network (BCAN) as a member of the Board of Directors, past chair of the Bladder Cancer Think Tank and co-chair of the management committee of the Bladder Cancer Research Network.
Dr. Lerner is highly rated in 12 conditions, according to our data. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Lymphadenectomy.
His clinical research consists of co-authoring 203 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
7200 Cambridge St., 10th Floor, Suite 10 B, Houston, TX 77030
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
9 Clinical Trials
MD Anderson
Curtis Pettaway is a Urologist and a Surgical Oncologist in Houston, Texas. Dr. Pettaway is highly rated in 12 conditions, according to our data. His top areas of expertise are Penile Cancer, Prostate Cancer, Familial Prostate Cancer, Penectomy, and Lymphadenectomy.
Baylor St. Luke's - O’Quinn Medical Tower At McNair
Dr. Alastair Thompson is a surgical oncologist specializing in breast cancer. He is the Professor and Chief of the Division of Surgical Oncology, Section of Breast Surgery at Baylor College of Medicine, where he holds the Olga Keith Wiess Chair of Surgery. He also serves as Co-Director of the Lester and Sue Smith Breast Center and is Co-Associate Director for Clinical Research at the Dan L Duncan Comprehensive Cancer Center.Dr. Thomspon’s clinical interests include: ductal carcinoma in situ (DCIS); nipple and skin sparing mastectomy; breast conservation surgery; and sentinel lymph node biopsy. His research interests include: multidisciplinary patient care alongside “bench to bedside” studies; and innovative clinical trials in cancer. He initiated and led a successful breast cancer laboratory program; provided leadership for a cancer center in the United Kingdom; chaired the UK national breast cancer trials portfolio of 120 studies; and engaged in a range of pivotal roles in key drug, radiation therapy and surgical trials involving the UK, Europe, United States and Australia.Dr. Thompson also has preclinical and practical experience in the design, implementation, monitoring and reporting of early- to late-phase drug and medical device trials. Dr. Thompson received his MBChB in Medicine Surgery and medical degree in Molecular Biology from the University of Edinburgh in Edinburgh, Scotland. He completed his residency in general surgery at the Royal Infirmary of Edinburgh and a Research Fellowship at the Imperial Cancer Research Fund in Edinburgh.Dr. Thompson has co-chaired the Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial for low-risk DCIS; and the National Cancer Institute (NCI)-Breast Cancer Steering Committee proposed “no surgery” clinical trial planning committee. He is a member of the NCI BOLD taskforce and has held leadership positions in the Translational Breast Cancer Research Consortium and SWOG Cancer Research Network.Dr. Thompson is also a member of the American Society of Clinical Oncology, Association of Breast Surgery, British Association of Surgical Oncology, British Breast Group, American Society of Breast Surgeons, American Association for Cancer Research, Moynihan Chirurgical Club, and the Society of Surgical Oncology. Dr. Thompson is highly rated in 6 conditions, according to our data. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Mastectomy, and Tissue Biopsy.
MD Anderson
Jean Vauthey is a Surgical Oncologist in Houston, Texas. Dr. Vauthey is highly rated in 17 conditions, according to our data. His top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Cancer, Liver Cancer, Hepatectomy, and Hepato-Pancreato-Biliary Surgery.
Frequently Asked Questions about Dr. Seth P. Lerner
How do I make an appointment with Dr. Seth P. Lerner?
You can book an appointment with Dr. Seth P. Lerner by calling their office at 713-798-4001. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Seth P. Lerner a top-rated expert for Bladder Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Seth P. Lerner is classified as an Elite expert for Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Seth P. Lerner specialize in?
While Dr. Seth P. Lerner is a Oncology, they have specific expertise in Bladder Cancer, Urothelial Cancer, and Cystectomy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Seth P. Lerner participate in research or clinical trials?
Yes. Dr. Seth P. Lerner has published 203 articles and abstracts on conditions like Bladder Cancer. You can view a list of Dr. Seth P. Lerner's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Seth P. Lerner accept my insurance?
Dr. Seth P. Lerner accepts most major insurance plans, including Aetna and Cigna. We recommend calling the office directly at 713-798-4001 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Bladder CancerDr. Lerner isElite. Learn about Bladder Cancer.
- CystectomyDr. Lerner isElite. Learn about Cystectomy.
- Muscle Invasive Bladder Cancer
- Non-Muscle Invasive Bladder Cancer
- Urothelial CancerDr. Lerner isElite. Learn about Urothelial Cancer.
- Distinguished
- LymphadenectomyDr. Lerner isDistinguished. Learn about Lymphadenectomy.
- Upper Tract Urothelial Carcinoma (UTUC)Dr. Lerner isDistinguished. Learn about Upper Tract Urothelial Carcinoma (UTUC).
- Advanced
- Bladder ReconstructionDr. Lerner isAdvanced. Learn about Bladder Reconstruction.
- HydronephrosisDr. Lerner isAdvanced. Learn about Hydronephrosis.
- NephrectomyDr. Lerner isAdvanced. Learn about Nephrectomy.
- Prostate CancerDr. Lerner isAdvanced. Learn about Prostate Cancer.
- Renal Cell Carcinoma (RCC)Dr. Lerner isAdvanced. Learn about Renal Cell Carcinoma (RCC).
- Experienced
- Adult Soft Tissue SarcomaDr. Lerner isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Bilateral HydronephrosisDr. Lerner isExperienced. Learn about Bilateral Hydronephrosis.
- Chromophobe Renal Cell CarcinomaDr. Lerner isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Chronic B-Cell Leukemia (CBCL)Dr. Lerner isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Dr. Lerner isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Clear Cell SarcomaDr. Lerner isExperienced. Learn about Clear Cell Sarcoma.
